Literature DB >> 20337985

Genome-wide analysis of POU3F2/BRN2 promoter occupancy in human melanoma cells reveals Kitl as a novel regulated target gene.

Dominique Kobi1, Anne-Lise Steunou, Doulaye Dembélé, Stéphanie Legras, Lionel Larue, Laurence Nieto, Irwin Davidson.   

Abstract

POU3F2 is a POU-Homeodomain transcription factor expressed in neurons and melanoma cells. In melanoma lesions, cells expressing high levels of POU3F2 show enhanced invasive and metastatic capacity that can in part be explained by repression of Micropthalmia-associated Transcription Factor (MITF) expression via POU3F2 binding to its promoter. To identify other POU3F2 target genes that may be involved in modulating the properties of melanoma cells, we performed ChIP-chip experiments in 501Mel melanoma cells. 2108 binding loci located in the regulatory regions of 1700 potential target genes were identified. Bioinformatic and experimental assays showed the presence of known POU3F2-binding motifs, but also many AT-rich sequences with only partial similarity to the known motifs at the occupied loci. Functional analysis indicates that POU3F2 regulates the stem cell factor (Kit ligand, Kitl) promoter via a cluster of four closely spaced binding sites located in the proximal promoter. Our results suggest that POU3F2 may regulate the properties of melanoma cells via autocrine KIT ligand signalling.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20337985     DOI: 10.1111/j.1755-148X.2010.00697.x

Source DB:  PubMed          Journal:  Pigment Cell Melanoma Res        ISSN: 1755-1471            Impact factor:   4.693


  22 in total

Review 1.  Regulation of melanocyte pivotal transcription factor MITF by some other transcription factors.

Authors:  Ping Wan; Yongqing Hu; Li He
Journal:  Mol Cell Biochem       Date:  2011-04-26       Impact factor: 3.396

2.  Retinoic acid receptors recognize the mouse genome through binding elements with diverse spacing and topology.

Authors:  Emmanuel Moutier; Tao Ye; Mohamed-Amin Choukrallah; Sylvia Urban; Judit Osz; Amandine Chatagnon; Laurence Delacroix; Diana Langer; Natacha Rochel; Dino Moras; Gerard Benoit; Irwin Davidson
Journal:  J Biol Chem       Date:  2012-06-01       Impact factor: 5.157

3.  Gbx2 directly restricts Otx2 expression to forebrain and midbrain, competing with class III POU factors.

Authors:  Fumitaka Inoue; Daisuke Kurokawa; Maiko Takahashi; Shinichi Aizawa
Journal:  Mol Cell Biol       Date:  2012-05-07       Impact factor: 4.272

Review 4.  The roles of microphthalmia-associated transcription factor and pigmentation in melanoma.

Authors:  Jennifer J Hsiao; David E Fisher
Journal:  Arch Biochem Biophys       Date:  2014-08-09       Impact factor: 4.013

5.  Inverse expression states of the BRN2 and MITF transcription factors in melanoma spheres and tumour xenografts regulate the NOTCH pathway.

Authors:  A E Thurber; G Douglas; E C Sturm; S E Zabierowski; D J Smit; S N Ramakrishnan; E Hacker; J H Leonard; M Herlyn; R A Sturm
Journal:  Oncogene       Date:  2011-02-28       Impact factor: 9.867

6.  Phosphorylation of BRN2 modulates its interaction with the Pax3 promoter to control melanocyte migration and proliferation.

Authors:  Irina Berlin; Laurence Denat; Anne-Lise Steunou; Isabel Puig; Delphine Champeval; Sophie Colombo; Karen Roberts; Elise Bonvin; Yveline Bourgeois; Irwin Davidson; Véronique Delmas; Laurence Nieto; Colin R Goding; Lionel Larue
Journal:  Mol Cell Biol       Date:  2012-01-30       Impact factor: 4.272

7.  Single-cell gene expression signatures reveal melanoma cell heterogeneity.

Authors:  M Ennen; C Keime; D Kobi; G Mengus; D Lipsker; C Thibault-Carpentier; I Davidson
Journal:  Oncogene       Date:  2014-08-18       Impact factor: 9.867

Review 8.  Beyond MITF: Multiple transcription factors directly regulate the cellular phenotype in melanocytes and melanoma.

Authors:  Hannah E Seberg; Eric Van Otterloo; Robert A Cornell
Journal:  Pigment Cell Melanoma Res       Date:  2017-09       Impact factor: 4.693

9.  A phosphatidylinositol 3-kinase-Pax3 axis regulates Brn-2 expression in melanoma.

Authors:  Elise Bonvin; Paola Falletta; Heather Shaw; Veronique Delmas; Colin R Goding
Journal:  Mol Cell Biol       Date:  2012-09-17       Impact factor: 4.272

Review 10.  Targeting the epigenetic machinery of cancer cells.

Authors:  M F Montenegro; L Sánchez-del-Campo; M P Fernández-Pérez; M Sáez-Ayala; J Cabezas-Herrera; J N Rodríguez-López
Journal:  Oncogene       Date:  2014-01-27       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.